• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环境因素对慢性阻塞性肺疾病患者miRNAs差异表达的影响:一项初步临床研究。

The effect of environmental factors on the differential expression of miRNAs in patients with chronic obstructive pulmonary disease: a pilot clinical study.

作者信息

Liu Peng-Fei, Yan Peng, Zhao Da-Hui, Shi Wen-Fang, Meng Song, Liu Yang, Liu Bin, Li Guo-Feng, Xie Li-Xin

机构信息

Department of Pulmonary and Critical Care Medicine, Chinese PLA General Hospital, Beijing.

Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Logistic University of Chinese People's Armed Police Force, Tianjin, People's Republic of China.

出版信息

Int J Chron Obstruct Pulmon Dis. 2018 Feb 28;13:741-751. doi: 10.2147/COPD.S156865. eCollection 2018.

DOI:10.2147/COPD.S156865
PMID:29535514
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5836692/
Abstract

OBJECTIVE

The objective of the study was to analyze the effect of environmental factors on the differential expression of microRNAs in the peripheral blood of migratory and local patients in northern People's Republic of China and on clinical symptoms of local patients in northern People's Republic of China with COPD.

METHODS

A total of 118 patients in the northern region and 8 migratory patients were enrolled in this prospective study. We collected general information. Blood samples were collected from 9 patients in the Beijing group, from 8 patients in the migratory group and from 9 healthy control subjects. After extracting the total RNA from these 3 groups, serum miRNA was identified by Solexa sequencing. We collected COPD assessment test (CAT) and Modified British Medical Research Council (mMRC) scores at different levels of air pollution and also collected the number of exacerbations over the year prior to the baseline and in the year preceding the follow-up.

RESULTS

In total 9 miRNAs were differentially expressed. When air quality index (AQI) >100, the CAT and mMRC scores at baseline were significantly higher than those when the AQI ≤100 (<0.001). When AQI >100, the follow-up CAT and mMRC scores were significantly higher than those when AQI ≤100 (<0.001). Follow-up mMRC scores were significantly higher than baseline scores (=0.04). When AQI ≤100, the baseline CAT score of the group with fewer symptoms was 6.50 (4.00-8.75). However, when AQI >100, the baseline CAT score of this fewer symptoms group was 10.00 (6.25-12.00). The median CAT score was close to 10. When AQI ≤100, the follow-up CAT score of the fewer symptoms group was 8.00 (4.25-12.00). However, when AQI >100, the follow-up CAT score of the fewer symptoms group was 9.50 (6.00-16.75). The median CAT score was close to 10.

CONCLUSION

Environmental factors may cause differential expression of miRNAs in the peripheral blood of migratory and local patients in northern People's Republic of China. Air pollution may aggravate clinical symptoms of patients with COPD.

摘要

目的

本研究旨在分析环境因素对中国北方迁徙和本地患者外周血中微小RNA差异表达的影响,以及对中国北方慢性阻塞性肺疾病(COPD)本地患者临床症状的影响。

方法

本前瞻性研究共纳入118例北方地区患者和8例迁徙患者。我们收集了一般信息。从北京组的9例患者、迁徙组的8例患者和9例健康对照者中采集血样。从这3组中提取总RNA后,通过Solexa测序鉴定血清微小RNA。我们收集了不同空气污染水平下的慢性阻塞性肺疾病评估测试(CAT)和改良英国医学研究委员会(mMRC)评分,还收集了基线前一年和随访前一年的急性加重次数。

结果

总共9种微小RNA存在差异表达。当空气质量指数(AQI)>100时,基线时的CAT和mMRC评分显著高于AQI≤100时(<0.001)。当AQI>100时,随访时的CAT和mMRC评分显著高于AQI≤100时(<0.001)。随访时的mMRC评分显著高于基线评分(=0.04)。当AQI≤100时,症状较轻组的基线CAT评分为6.50(4.00 - 8.75)。然而,当AQI>100时,该症状较轻组的基线CAT评分为10.00(6.25 - 12.00)。CAT评分中位数接近10。当AQI≤100时,症状较轻组的随访CAT评分为8.00(4.25 - 12.00)。然而,当AQI>100时,该症状较轻组的随访CAT评分为9.50(6.00 - 16.75)。CAT评分中位数接近10。

结论

环境因素可能导致中国北方迁徙和本地患者外周血中微小RNA的差异表达。空气污染可能加重COPD患者的临床症状。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/5836692/693f91ca4dd7/copd-13-741Fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/5836692/69f9a984a595/copd-13-741Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/5836692/fd6ebe8b801d/copd-13-741Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/5836692/242e1140a1bd/copd-13-741Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/5836692/110245cdc948/copd-13-741Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/5836692/4dfa365de971/copd-13-741Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/5836692/08e3b4ecc90c/copd-13-741Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/5836692/ab7b5f8e6491/copd-13-741Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/5836692/705fcf70e784/copd-13-741Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/5836692/9afd57f08b95/copd-13-741Fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/5836692/693f91ca4dd7/copd-13-741Fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/5836692/69f9a984a595/copd-13-741Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/5836692/fd6ebe8b801d/copd-13-741Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/5836692/242e1140a1bd/copd-13-741Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/5836692/110245cdc948/copd-13-741Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/5836692/4dfa365de971/copd-13-741Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/5836692/08e3b4ecc90c/copd-13-741Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/5836692/ab7b5f8e6491/copd-13-741Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/5836692/705fcf70e784/copd-13-741Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/5836692/9afd57f08b95/copd-13-741Fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b48/5836692/693f91ca4dd7/copd-13-741Fig10.jpg

相似文献

1
The effect of environmental factors on the differential expression of miRNAs in patients with chronic obstructive pulmonary disease: a pilot clinical study.环境因素对慢性阻塞性肺疾病患者miRNAs差异表达的影响:一项初步临床研究。
Int J Chron Obstruct Pulmon Dis. 2018 Feb 28;13:741-751. doi: 10.2147/COPD.S156865. eCollection 2018.
2
[Influence of environmental factors on the migratory birds population with chronic obstructive pulmonary disease].[环境因素对患有慢性阻塞性肺疾病的候鸟种群的影响]
Zhonghua Yi Xue Za Zhi. 2015 Sep 22;95(36):2924-7.
3
Peripheral leukocyte microRNAs as novel biomarkers for COPD.外周血白细胞微小RNA作为慢性阻塞性肺疾病的新型生物标志物
Int J Chron Obstruct Pulmon Dis. 2017 Apr 6;12:1101-1112. doi: 10.2147/COPD.S130416. eCollection 2017.
4
Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma-COPD overlap syndrome phenotype.慢性阻塞性肺疾病(COPD)、哮喘及哮喘-COPD重叠综合征表型患者血清和痰液中miRNA-145与miRNA-338的表达谱分析
Int J Chron Obstruct Pulmon Dis. 2017 Jun 23;12:1811-1817. doi: 10.2147/COPD.S130616. eCollection 2017.
5
Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD.慢性阻塞性肺疾病(COPD)患者改良医学研究委员会呼吸困难评分与COPD评估测试评分之间的差异
Int J Chron Obstruct Pulmon Dis. 2015 Aug 12;10:1623-31. doi: 10.2147/COPD.S87147. eCollection 2015.
6
Chronic obstructive pulmonary disease assessment test: usefulness for monitoring recovery and predicting poor course of disease after exacerbations.慢性阻塞性肺疾病评估测试:在监测康复和预测加重后疾病不良进程方面的作用。
Emergencias. 2019 Feb;31(1):21-26.
7
Clinical application of the COPD assessment test: longitudinal data from the COPD History Assessment in Spain (CHAIN) cohort.COPD 评估测试的临床应用:来自西班牙 COPD 病史评估(CHAIN)队列的纵向数据。
Chest. 2014 Jul;146(1):111-122. doi: 10.1378/chest.13-2246.
8
Effect of ambient air quality on exacerbation of COPD in patients and its potential mechanism.大气环境质量对 COPD 患者恶化的影响及其潜在机制。
Int J Chron Obstruct Pulmon Dis. 2019 Jul 10;14:1517-1526. doi: 10.2147/COPD.S190600. eCollection 2019.
9
Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD.改良医学研究委员会呼吸困难量表、慢性阻塞性肺疾病评估测试及临床慢性阻塞性肺疾病问卷在慢性阻塞性肺疾病新全球倡议分期及死亡率中对症状评估的差异效应
Chest. 2015 Jul;148(1):159-168. doi: 10.1378/chest.14-2449.
10
Chronic obstructive pulmonary disease (COPD) assessment test scores corresponding to modified Medical Research Council grades among COPD patients.慢性阻塞性肺疾病(COPD)患者中与改良医学研究委员会分级相对应的COPD评估测试分数。
Korean J Intern Med. 2015 Sep;30(5):629-37. doi: 10.3904/kjim.2015.30.5.629. Epub 2015 Aug 27.

引用本文的文献

1
MicroRNAs as promising drug delivery target to ameliorate chronic obstructive pulmonary disease using nano-carriers: a comprehensive review.利用纳米载体将微小RNA作为改善慢性阻塞性肺疾病的有前景的药物递送靶点:综述
Mol Cell Biochem. 2025 Mar;480(3):1431-1448. doi: 10.1007/s11010-024-05110-0. Epub 2024 Sep 10.
2
Analysis of Differentially Expressed MicroRNAs in Serum and Lung Tissues from Individuals with Severe Asthma Treated with Oral Glucocorticoids.口服糖皮质激素治疗的重度哮喘患者血清和肺组织中差异表达 microRNAs 的分析。
Int J Mol Sci. 2023 Jan 13;24(2):1611. doi: 10.3390/ijms24021611.
3
MiR-361-5p/ and MiR-196-5p/ Axis Involved in γ-Sitosterol Inducing Dual Anti-Proliferative Effects on Bronchial Epithelial Cells of Chronic Obstructive Pulmonary Disease.

本文引用的文献

1
[Influence of environmental factors on the migratory birds population with chronic obstructive pulmonary disease].[环境因素对患有慢性阻塞性肺疾病的候鸟种群的影响]
Zhonghua Yi Xue Za Zhi. 2015 Sep 22;95(36):2924-7.
2
Features of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional study.比较 CAT 与 mMRC 对 COPD 患者特征的影响:一项回顾性、横断面研究。
NPJ Prim Care Respir Med. 2015 Nov 5;25:15063. doi: 10.1038/npjpcrm.2015.63.
3
Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD.
miR-361-5p/和 miR-196-5p/ 轴参与 γ-谷甾醇诱导慢性阻塞性肺疾病支气管上皮细胞的双重抗增殖作用。
Int J Chron Obstruct Pulmon Dis. 2021 Oct 5;16:2741-2753. doi: 10.2147/COPD.S326015. eCollection 2021.
4
Association Between Air Pollution and Lung Lobar Emphysema in COPD.慢性阻塞性肺疾病中空气污染与肺叶肺气肿之间的关联
Front Med (Lausanne). 2021 Sep 21;8:705792. doi: 10.3389/fmed.2021.705792. eCollection 2021.
5
MicroRNAs as Potential Regulators of Immune Response Networks in Asthma and Chronic Obstructive Pulmonary Disease.微小 RNA 作为哮喘和慢性阻塞性肺疾病中免疫反应网络的潜在调节因子。
Front Immunol. 2021 Jan 8;11:608666. doi: 10.3389/fimmu.2020.608666. eCollection 2020.
6
The Impact of Air Pollution on Our Epigenome: How Far Is the Evidence? (A Systematic Review).空气污染对我们表观基因组的影响:证据有多少?(系统评价)
Curr Environ Health Rep. 2018 Dec;5(4):544-578. doi: 10.1007/s40572-018-0218-8.
改良医学研究委员会呼吸困难量表、慢性阻塞性肺疾病评估测试及临床慢性阻塞性肺疾病问卷在慢性阻塞性肺疾病新全球倡议分期及死亡率中对症状评估的差异效应
Chest. 2015 Jul;148(1):159-168. doi: 10.1378/chest.14-2449.
4
Clinical application of exhaled nitric oxide measurements in a korean population.呼出气一氧化氮测量在韩国人群中的临床应用。
Allergy Asthma Immunol Res. 2015 Jan;7(1):3-13. doi: 10.4168/aair.2015.7.1.3. Epub 2014 Aug 19.
5
Breathlessness or health status in chronic obstructive pulmonary disease: the impact of different definitions.慢性阻塞性肺疾病中的呼吸困难或健康状况:不同定义的影响。
COPD. 2015 Apr;12(2):115-25. doi: 10.3109/15412555.2014.974741. Epub 2014 Dec 4.
6
Comparison of symptom and risk assessment methods among patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者症状与风险评估方法的比较
Chin Med J (Engl). 2014;127(14):2594-8.
7
Airway inflammation in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的气道炎症
J Thorac Dis. 2014 Mar;6 Suppl 1(Suppl 1):S167-72. doi: 10.3978/j.issn.2072-1439.2014.03.07.
8
Air pollution and biomarkers of systemic inflammation and tissue repair in COPD patients.空气污染与 COPD 患者全身炎症和组织修复生物标志物。
Eur Respir J. 2014 Sep;44(3):603-13. doi: 10.1183/09031936.00168813. Epub 2014 Feb 20.
9
Clinical application of the COPD assessment test: longitudinal data from the COPD History Assessment in Spain (CHAIN) cohort.COPD 评估测试的临床应用:来自西班牙 COPD 病史评估(CHAIN)队列的纵向数据。
Chest. 2014 Jul;146(1):111-122. doi: 10.1378/chest.13-2246.
10
Association of ambient air pollution with the prevalence and incidence of COPD.大气污染与 COPD 患病率和发病率的关系。
Eur Respir J. 2014 Sep;44(3):614-26. doi: 10.1183/09031936.00132213. Epub 2014 Jan 31.